Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Amylyx revenue
Amylyx's revenue is $87.4 million.
What is Amylyx's revenue?
- Amylyx's revenue growth from 2020 to 2024 is 13,341.69%.
- Amylyx has 205 employees, and the revenue per employee ratio is $426,200.
- Amylyx's peak quarterly revenue was $108.4M in 2023(q4).
- Amylyx peak revenue was $380.8M in 2023.
- Amylyx annual revenue for 2023 was 380.8M, 1,612.94% growth from 2022.
- Amylyx annual revenue for 2024 was 87.4M, -77.06% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Amylyx historical revenue
Amylyx's peak revenue was $380.8M in 2023. The peak quarterly revenue was $108.4M in 2023(q4).
Amylyx's revenue increased from $650.0k in 2020 to $87.4M currently. That's a 13,341.69% change in annual revenue.
Amylyx annual revenue
Amylyx annual revenue over time
| Fiscal year / year | Amylyx revenue |
|---|---|
| 2020 | $650,000 |
| 2021 | $285,000 |
| 2022 | $22.2M |
| 2023 | $380.8M |
| 2024 | $87.4M |
Rate Amylyx's financial transparency
Amylyx annual growth
Amylyx saw the greatest revenue growth in 2022, when revenue increased by 7,700.0%.
Amylyx had the lowest revenue growth in 2021, when revenue changed by -56.15%.
Amylyx annual growth rate over time
| Year | Amylyx growth |
|---|---|
| 2021 | -56%↓ |
| 2022 | 7700%↑ |
| 2023 | 1613%↑ |
| 2024 | -77%↓ |
Amylyx quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Amylyx quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2022 | - | - | $345,000 | $21.9M |
| 2023 | $71.4M | $98.2M | $102.7M | $108.4M |
| 2024 | $88.6M | ($1.0M) | $416,000 | ($665.0K) |
Amylyx jobs nearby
Do you work at Amylyx?
Is Amylyx transparent about its revenue structure?
Amylyx financial information
| CEO | Joshua B. Cohen |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 205 |
| Date Founded | 2014 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $87.4M |
| Net Income | -$198,375,000 |
| Gross Proft | $81.4M (2024) |
| Tax Rate | 0.0% |
| Total Assets | $391,453,000 |
| Ticker | AMLX |
Amylyx jobs you might like
Amylyx financing
Amylyx received early financing of $1.4M on 2015-11-17.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $1.4M | 11/2015 |
| Seed | $3.0M | 07/2016 |
| Series A | $5M | 08/2016 |
| Debt Financing | $13.0M | 11/2018 |
| Debt Financing | $14.8M | 01/2020 |
| Series B | $30M | 07/2020 |
| Series C | $135M | 07/2021 |
Amylyx investors
| Investors | Security type |
|---|---|
| The ALS Association | Seed |
| ALS Finding a Cure | Seed |
| Morningside Group | Series A |
| ALS Investment Fund | Series A |
| Lysosomal Therapeutics Inc | Series A |
| Morningside Venture Investments | Series B |
| DRADS Capital | Series B |
| 683 CAPITAL | Series C |
| Woodline Partners LP | Series C |
| Bain Capital Life Sciences | Series C |
| Alpha Wave Global LP | Series C |
| Marshall Wace | Series C |
| Morningside Venture Investments | Series C |
| Viking Global Investors | Series C |
| Tybourne Capital Management | Series C |
| Polaris Founders Capital | Series C |
| Perceptive Advisors | Series C |
| Belinda Termeer | Series C |
| aMoon Fund | Series C |
| Rock Springs Capital | Series C |
| Verition Fund Management LLC | Series C |
Amylyx competitors
Amylyx's top competitor, Regeneron, earned an annual revenue of $14.2B.
Amylyx's smallest competitor is Arena Pharmaceuticals with revenue of $54.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| ProMIS Neurosciences | - | $284.9K | 15 | - |
| Brainstorm Cell Therapeutics | - | $82,000 | 40 | - |
| Cognition Therapeutics | - | $19.5M | 30 | - |
| Accera | - | $5.5M | 75 | - |
| Aquestive Therapeutics | - | $57.6M | 100 | - |
| NervGen Pharma | - | $1.6M | 13 | - |
| Q Holdings | - | $1.6M | 15 | - |
| Regeneron | - | $14.2B | 9,123 | - |
| Arena Pharmaceuticals | - | $54,000 | 194 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Amylyx, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Amylyx. The employee data is based on information from people who have self-reported their past or current employments at Amylyx. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Amylyx. The data presented on this page does not represent the view of Amylyx and its employees or that of Zippia.
Amylyx may also be known as or be related to Amylyx, Amylyx Pharmaceuticals, Amylyx Pharmaceuticals Inc and Amylyx Pharmaceuticals, Inc.